7National Comprehensive Cancer Network.NCCN clinical prac-tice guidelines in oncology[J].Breast Cancer,2008[EB/OL].
8Dowlatshahi K,Alvarado R,Harrison M,et a1.Five yeai follow-up of patients with operable breasl cancer whose sentinol nodes were completely sectioned at0.25mm[J].Cancer Res,2009,69(1):1017.
9Solin LJ,Fourquet A,Mccorrnick B,et al.Salvage treatment for local recurrence following breast-conserving surgery and definitive irrad iationfor ductal carcinoma of the reast[J].Int J Ra-diatned Phys Biol,1994,30(1):3-6.
10Clarke M,Collins R,Darby S,et al.Effects of radiotherapy and of differences in the extent of surgery for early breast can-cer on local recurrence and152year survival:an overview of the randomised trials[J].Lancet,2005,366(9503):2087-2106.
4Tavassoli FA, Devilee P. The WHO classification of tumors of the breast and female genital organs[M]. Lyon: IARC Press,2003:10-112.
5Menendez D, Nguyen TA, Freudenberg JM, et al. Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells[J]. Nu- cleic Acids Res,2013,41(15):7286-7301.
6Walerych D, Napoli M, Collavin L, et al. The rebel angel: mutant p53 as the driving oncogene in breast cancer[J]. Carcinogenesis,2012,33(11):2007-2017.
7Varna M, Bousquet G, Plassa LF, et al. TP53 status and response to treatment in breast cancers[J]. J Biomed Biotechnol,2011,2011:284584.
9Boissan M, Lacombe ML. NM23, an example of a metas- tasis suppressor gene[J]. Bull Caneer,2012,99(4):431-440.
10Cubukcu E, Kanat O, Fatih Olmez O, et al. Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer[J]. J BUON,2013,18(2):359-365.
